Skip to main content
All lobbying filings

GRAYROBINSON PA

Lobbying for OMEROS CORPORATION · Biopharmaceutical company focused on small-molecule and protein therapeutics.

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 20, 2025
Income
$45,000.00
What the client paid this registrant for the period.
Client based in
Washington

Official filing document

 Government bodies contacted 3
  • Executive Office of the President (EOP)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Medicare/Medicaid

Separate payment policies for non-opioid alternatives.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem